Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Latest, FY2025
90,586
Period ended Dec 31, 2025
Change on a year earlier
-1.4%
91,839 in FY2024
History
18 years
Since FY2008
Sources
18
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total liabilities and stockholders' equity ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 90,586 | -1.4% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 91,839 | -5.5% | Form 10-K (filed 2025-02-14) ↗ |
| FY2023 | Dec 31, 2023 | 97,154 | +49.2% | Form 10-K (filed 2024-02-14) ↗ |
| FY2022 | Dec 31, 2022 | 65,121 | +6.5% | Form 10-K (filed 2023-02-09) ↗ |
| FY2021 | Dec 31, 2021 | 61,165 | -2.8% | Form 10-K (filed 2022-02-16) ↗ |
| FY2020 | Dec 31, 2020 | 62,948 | +5.4% | Form 10-K (filed 2021-02-09) ↗ |
| FY2019 | Dec 31, 2019 | 59,707 | -10.1% | Form 10-K (filed 2020-02-12) ↗ |
| FY2018 | Dec 31, 2018 | 66,416 | -16.9% | Form 10-K (filed 2019-02-13) ↗ |
| FY2017 | Dec 31, 2017 | 79,954 | +3.0% | Form 10-K (filed 2018-02-13) ↗ |
| FY2016 | Dec 31, 2016 | 77,626 | +8.6% | Form 10-K (filed 2017-02-14) ↗ |
| FY2015 | Dec 31, 2015 | 71,449 | +3.5% | Form 10-Q (filed 2016-05-02) ↗ |
| FY2014 | Dec 31, 2014 | 69,009 | +4.4% | Form 10-K (filed 2015-02-19) ↗ |
| FY2013 | Dec 31, 2013 | 66,125 | +21.8% | Form 10-K (filed 2014-02-24) ↗ |
| FY2012 | Dec 31, 2012 | 54,298 | +11.1% | Form 10-K (filed 2013-02-27) ↗ |
| FY2011 | Dec 31, 2011 | 48,871 | +12.4% | Form 10-K (filed 2012-02-29) ↗ |
| FY2010 | Dec 31, 2010 | 43,486 | +9.7% | Form 10-K (filed 2011-02-25) ↗ |
| FY2009 | Dec 31, 2009 | 39,629 | +8.8% | Form 10-K (filed 2010-03-01) ↗ |
| FY2008 | Dec 31, 2008 | 36,427 | – | Form 10-Q (filed 2009-08-10) ↗ |
Cite this data
StockData. (2026). Amgen Total liabilities and stockholders' equity ($M) ($M), annual FY2008–FY2025 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_tl_eq
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.